First Personal Financial Services Bluebird Bio, Inc. Transaction History

First Personal Financial Services

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 15, 2019	SELL	$59.47 - $93.1 $2,735 - $4,282	-46 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$59.1 - $93.26 $2,718 - $4,289	46 New	46 $5,000
Q2 2018 Aug 07, 2018	SELL	$99.64 - $127.59 $7,871 - $10,079	-79 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$105.8 - $150.94 $6,348 - $9,056	-60 Reduced 43.17%	79 $13,000
Q4 2017 Jan 25, 2018	SELL	$81.25 - $130.7 $5,362 - $8,626	-66 Reduced 32.2%	139 $25,000
Q3 2017 Nov 01, 2017	BUY	$57.74 - $91.42 $11,836 - $18,741	205	205 $28,000

150

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $601M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

Stay updated on First Personal Financial Services with notifications on news.